Diabetic neuropathy is diagnosed through a combination of symptom history, physical examination, and targeted nerve function tests. There’s no single test that confirms it. Instead, your doctor pieces together findings from several assessments while ruling out other causes of nerve damage. The process typically starts with simple, painless bedside tests and only moves to more advanced studies if the picture is unclear.
When Screening Should Start
The timing of your first neuropathy screening depends on which type of diabetes you have. If you have type 2 diabetes, screening should happen at the time of diagnosis, because nerve damage may already be underway by the time blood sugar levels are caught. If you have type 1 diabetes, screening should begin five years after diagnosis. After that initial check, you should be evaluated annually. These recommendations come from the 2024 ADA Standards of Care.
Annual screening matters because neuropathy often develops gradually. Many people have measurable nerve damage before they notice any symptoms at all. Early detection gives you the best chance of slowing progression through tighter blood sugar control.
Symptom History and Clinical Assessment
The diagnostic process starts with your doctor asking detailed questions about what you’re feeling and where. Peripheral neuropathy, the most common form, typically causes tingling, pain, numbness, or weakness in the feet and hands. It follows a “stocking-glove” pattern, starting at the toes and gradually moving upward. Your doctor will want to know when symptoms started, whether they’re constant or come and go, and whether they’re worse at night.
Autonomic neuropathy affects the nerves that control involuntary body systems, so the questions shift to things like dizziness when standing, digestive problems, bladder issues, or changes in sweating. These symptoms can overlap with many other conditions, which is why the clinical history is just the starting point.
Bedside Sensory Tests
The physical exam includes a few straightforward tests you’ll likely recognize if you’ve had a diabetic foot exam. The most common is the monofilament test, which uses a thin nylon fiber pressed against specific spots on your feet, usually the big toe and heel. When the fiber bends, it applies exactly 10 grams of pressure. If you can’t feel it, you’ve lost what’s called “protective sensation,” the basic ability to detect pressure that helps prevent foot injuries.
The monofilament test is quick and widely used, but it has real limitations. Its sensitivity for detecting neuropathy is around 53%, meaning it misses roughly half of cases. That’s why it’s rarely used alone. Your doctor will typically combine it with at least one other sensory test to get a more reliable picture.
A tuning fork test checks your ability to sense vibration. Your doctor strikes a 128 Hz tuning fork and places it on the joint of your big toe. You’ll be asked to say when the vibration stops. If you can no longer feel it while the fork is still vibrating, your doctor moves the fork to a higher spot, like the ankle bone, then the shin, then the knee. This maps how far up the leg the nerve damage extends. Loss of vibration sense points to damage in the large nerve fibers, the ones responsible for balance and position awareness.
Other bedside checks may include testing your ability to distinguish sharp from dull touch using a pin, assessing temperature sensation, and checking your ankle reflexes. Reduced or absent ankle jerks are a common early sign.
Nerve Conduction Studies
If bedside tests suggest neuropathy but the diagnosis isn’t clear, or if your doctor needs to understand the severity, nerve conduction studies (NCS) provide more objective data. These tests measure how fast electrical signals travel through your nerves and how strong those signals are.
In typical diabetic neuropathy, the electrical responses from sensory nerves in the legs are reduced or absent. This reflects the gradual loss of large nerve fibers, starting at the longest nerves first (which is why the feet are affected before the hands). Nerve conduction speed is usually normal or only mildly slowed. If speeds drop below 70% of the normal lower limit, or if signals are blocked entirely in certain segments, that suggests something beyond standard diabetic nerve damage, possibly an additional inflammatory condition affecting the nerve insulation.
As neuropathy progresses, the motor nerves (the ones controlling muscle movement) also show reduced signal strength, and abnormalities may appear in the hands. The test itself involves small electrical impulses delivered through pads on your skin. It’s uncomfortable but not typically painful, and results are available the same day.
Skin Biopsy for Small Fiber Neuropathy
Nerve conduction studies are excellent for detecting damage to large nerve fibers, but they can come back completely normal in people whose small fibers are affected. Small fiber neuropathy causes burning pain, shooting sensations, and temperature sensitivity, sometimes before any other tests show anything wrong. This is where a skin biopsy becomes valuable.
The procedure is simple: a tiny circular punch of skin, usually about 3 millimeters wide, is taken from the lower leg near the ankle. A pathologist then counts the number of tiny nerve endings threading up through the outer layer of skin. In healthy adults, the distal leg normally has about 13.8 nerve fibers per millimeter of skin. When the count falls below about 3.8 per millimeter (the fifth percentile of the normal range), small fiber neuropathy is confirmed.
This test has strong diagnostic accuracy. Using that threshold, it correctly identifies neuropathy in 75% of positive cases and correctly rules it out in 90% of negative cases, for an overall diagnostic efficiency of 88%. A biopsy from the thigh can also be taken for comparison, since damage that’s worse at the ankle than the thigh supports the length-dependent pattern typical of diabetic neuropathy.
Autonomic Nerve Testing
When symptoms suggest autonomic neuropathy, a different set of tests comes into play. The gold standard involves cardiovascular autonomic reflex tests, a series of four assessments that measure how your heart rate and blood pressure respond to specific challenges. These include deep breathing (checking whether your heart rate rises and falls normally with each breath), a Valsalva maneuver (bearing down as if straining), and standing up from a lying position (to check for both heart rate changes and blood pressure drops).
A significant drop in blood pressure upon standing, called orthostatic hypotension, is one of the more telling signs. These tests are painless and take about 20 to 30 minutes. Having abnormal results on two or more of the four tests is generally considered confirmatory for cardiovascular autonomic neuropathy.
Ruling Out Other Causes
Not all nerve damage in a person with diabetes is caused by diabetes. Your doctor needs to rule out other conditions that can look identical. Blood tests are a standard part of the workup, including HbA1c to confirm diabetes status and tests for nutritional deficiencies. Deficiencies in vitamins B1, B6, B9 (folic acid), B12, E, and copper can all cause neuropathy. Interestingly, too much vitamin B6 can also damage nerves.
B12 deficiency deserves special attention because metformin, one of the most commonly prescribed diabetes medications, can lower B12 levels over time. Other conditions that mimic diabetic neuropathy include thyroid disease, kidney disease, chronic alcohol use, and certain autoimmune conditions. Your doctor may also check for inflammatory markers or protein abnormalities depending on your specific symptoms and how they’ve progressed.
Corneal Confocal Microscopy
A newer, non-invasive option involves using a specialized microscope to photograph the tiny nerve fibers in the clear front surface of your eye. The cornea is one of the most densely innervated tissues in the body, and the small nerve fibers there degenerate in a pattern that mirrors what’s happening in the feet. This technique, called corneal confocal microscopy, can detect nerve fiber loss even in early-stage neuropathy.
Studies have shown that all measures of corneal nerve density are significantly reduced in people with diabetic neuropathy compared to healthy controls. Nerve loss is especially pronounced in the lower region of the cornea, where fiber density drops roughly three times more than in the central cornea. People with painful neuropathy show even greater corneal nerve loss than those with painless neuropathy. The scan takes only a few minutes, requires no needles or biopsies, and is completely painless. It’s increasingly available at specialized centers, though it hasn’t yet replaced traditional testing in routine clinical practice.